1. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
2. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
3. What are "Medicated Cosmetics" under Schedule-I?
4. When can deviations be made from the information submitted during the registration of a drug?
5. What is the age requirement for the Chief Executive Officer (CEO) of the Authority?
6. For veterinary drugs, what is the source of specifications if they are not approved by the Registration Board?
7. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
8. In which situations may the Registration Board provisionally register a drug for a period of two years?
9. Who is considered an "investigator" under the Drugs (Research) Rules?
10. What is the purpose of Schedule-III of the DRAP Act?
11. What kind of offense is non-cognizable under the Drugs Act 1976?
12. What condition must be met for a drug or substance to be advertised through press without reference to the Federal Government?
13. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
14. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
15. Who serves as the ex-officio Chairman of the Appellate Board?
16. Which of the following is NOT considered as "Therapeutic goods" under the Act?
17. What substances are NOT included in the definition of "Drug" under Schedule-I?
18. What is the definition of "Biological Drugs (Ready-to-fill form)" under Schedule-I?
19. According to the Drug Licensing, Registering & Advertisement rules 1976, what type of information should advertisements to physicians and health-related professionals be consistent with?
20. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
21. What type of containers are ophthalmic solutions and suspensions required to be contained in?
22. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
23. How often must records of quarterly production and disposal of a drug be supplied to the Chairman of the Registration Board?
24. Which authority may authorize a Federal Inspector to disclose information acquired during official duties?
25. What are "Medicated Cosmetics" under Schedule-I?
26. When does an Inspector need to divide a sample into three portoons instead of four?
27. Which authority is responsible for issuing licences to manufacture drugs by way of repacking under section 18 of ordinance in a province?
28. What is the maximum quantity of a single drug that can be imported for personal use without exceeding the limit?
29. What is the purpose of an "airlock" in pharmaceutical manufacturing?
30. What is the purpose of the Committee on Drugs Evaluation?
31. In case an exporter's license is suspended or canceled, what recourse does the licensee have?
32. Within what time frame should the Authority submit its annual report to the Federal Government?
33. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
34. What is the purpose of 'the Drugs (Federal Inspectors, Federal Drug Laboratory and Federal Government Analysts) Rules, 1976'?
35. Which of the following statements about advertisement material is NOT true?
36. What is the role of the Quality Control Department in the manufacturing process?
37. What form should be used for applying for the grant or renewal of a licence to manufacture drugs?
38. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
39. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
40. What is the fee for the renewal of registration of a new drug?
41. What is the primary focus of basic research in the context of the Drugs (Research) Rules?
42. Which power of the Inspector requires specific authorization by the Government?
43. How many members does the Policy Board consist of?
44. What is the purpose of the license to manufacture drugs for experimental purposes?
45. What does the term "Advertise" mean under Schedule-II?
46. Who shall not be liable for a contravention of Section 23 of the Drugs Act 1976?
47. In what type of premises should the manufacturing of drugs by way of basic or semi-basic manufacture take place?
48. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
49. What is the purpose of Form 6?
50. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
51. In what situations can a drug or substance be advertised to the medical, pharmaceutical, and allied professions without referring to the Federal Government?
52. Which power of the Inspector requires specific authorization by the Government?
53. What is the purpose of Schedule-III of the DRAP Act?
54. Which of the following criteria should promotional claims about drugs adhere to?
55. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
56. What action should the Authority take in response to objections raised by the Auditor-General?
57. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
58. Who may physically inspect an imported consignment, draw samples, and order the importer not to sell or dispose of the drug for a specific period?
59. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
60. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
61. What is the Appellate Board's authority to call for the record of a case for review?
62. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
63. Who has the power to institute a prosecution for a contravention of any provision of the DRAP Act, 2012, and The Drugs Act, 1976?
64. Which of the following offenses punishable under Schedule-III is non-cognizable?
65. What is the maximum duration for which the approval of an advertisement under sub-rule (1) is valid?
66. Within what time frame should the Authority submit its annual report to the Federal Government?
67. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
68. What must be included in the labelling and promotion of a registered drug?
69. For drugs other than those falling under specific categories, whose approval is required for the specifications?
70. What does an Inspector require from a person during a search or seizure under Schedule-V?
71. Which of the following offenses punishable under Schedule-III is non-cognizable?
72. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
73. Which of the following substances would NOT be considered a "Medicated Cosmetic"?
74. What ethical criteria should be followed for medical drug promotion?
75. Who qualifies as a Federal Inspector according to these rules?
76. What is the purpose of the criteria regarding medical representatives?
77. What is the purpose of Form 10 in the export of drugs?
78. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
79. How long do members, other than ex-officio members, of the Appellate Board hold office for initially?
80. What authority is responsible for inspecting and regulaying the manufacturing of drugs under 1976 rules?
81. What are "Medical Devices" under Schedule-I?
82. What condition must be met for an application for renewal of a licence to be entertained?
83. What labeling requirements apply to drugs manufactured for experimental purposes?
84. In what circumstances shall a drug not be deemed misbranded or adulterated?
85. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
86. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
87. What is the maximum allowable retailer's discount for drugs?
88. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
89. The Central Research Fund fee collected by the Authority will be utilized for:
90. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
91. What information should be included in the written contract between the contract giver and contract acceptor for contract manufacture?
92. Who is responsible for maintaining records of quarterly production and disposal of a drug?
93. What degree qualifications are required for the competent technical staff involved in the manufacture of drugs by way of basic or semi-basic manufacture?
94. What is the maximum duration of a licence issued under Drugs Licensing, Registering & Advertising rules 1976?
95. What is the purpose of a separate application for manufacturing drugs on more than one set of premises?
96. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
97. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
98. Who is responsible for carrying out the audit of the Authority's accounts?
99. What substances are NOT included in the definition of "Drug" under Schedule-I?
100. What is the tenure of the CEO's appointment, and how many times can it be extended?
